A failure to warn claim is a product liability lawsuit that holds a manufacturer, distributor, or retailer responsible when a product injures someone because it was sold without adequate warnings or safety instructions about a hidden danger. These claims, also called marketing defect claims, focus on the information packaged with the product rather than how it was designed or built, and they can reach every business in the distribution chain. To win, you generally need to show that the product carried a foreseeable risk that was not obvious, that reasonable warnings would have reduced that risk, and that you were injured as a result.
When a Warning Is Legally Inadequate
The core rule comes from the Restatement (Second) of Torts Section 402A, which imposes liability on anyone who sells a product “in a defective condition unreasonably dangerous to the user or consumer.”1The Climate Change and Public Health Law Site. Restatement (Second) of Torts Section 402A and 402B Comment j to that section provides that a product accompanied by adequate warnings is not defective. Flip that around and the duty becomes clear: if a product carries risks that are not obvious to an ordinary consumer, the seller must communicate them.
The Restatement (Third) of Torts: Products Liability Section 2(c) sharpens the standard. A product is defective when “the foreseeable risks of harm posed by the product could have been reduced or avoided by the provision of reasonable instructions or warnings” and the absence of those warnings “renders the product not reasonably safe.” Foreseeability is the hinge. If the manufacturer could reasonably anticipate how the product might cause injury, the duty to warn attaches.
Courts look at practical factors when deciding whether a warning did its job. It has to be conspicuous: placed where a consumer will see it, in a readable font, and formatted to draw attention. It has to communicate the severity of the risk, not just hint that one exists. Telling someone to “use caution” around a chemical that causes permanent lung damage falls short. A good warning also explains how to avoid the danger, not just that one is present.
One important boundary. Manufacturers have no duty to warn about dangers that are open and obvious. A knife is sharp. A stove gets hot. The duty applies when the risk is hidden or counterintuitive, like a household cleaner that releases toxic fumes when mixed with another common product.
Strict Liability and Negligence Are Two Different Standards
A failure-to-warn claim can be brought on either theory, and the difference affects which cases win.
Under negligence, you must show the manufacturer failed to warn about a risk it knew or should have known about, and that a reasonably careful manufacturer in the same position would have included a warning. The focus is on the company’s conduct.
Strict liability drops the question of whether the manufacturer behaved reasonably. The question becomes whether the product lacked warnings about a risk that was known or knowable based on the best scientific and medical information available at the time. A manufacturer whose own testing came back clean might escape a negligence claim because its behavior was arguably reasonable. The same manufacturer can still lose under strict liability if the broader scientific community had already flagged the risk. Pharmaceutical and chemical exposure cases often turn on this distinction.
Proving the Warning Would Have Mattered
Showing a warning was inadequate is only half the case. You also have to show that a proper warning would have prevented your injury. If you would have ignored a warning anyway, the inadequate label did not cause your harm, and the claim fails.
Roughly half the states ease this burden through what is called the heeding presumption. Once you establish that a warning was absent or inadequate, the court presumes you would have followed a proper one. The burden then shifts to the manufacturer to prove you would have disregarded it. The presumption is rebuttable. If a worker routinely bypassed other safety labels on similar products, the defendant may convince the jury this warning would have been ignored too.
In states without the heeding presumption, you have to prove causation directly, usually through your own testimony about your habits and label-reading practices, often supported by expert testimony on consumer behavior. The causation element becomes significantly harder in those jurisdictions.
Who You Can Sue
Liability does not stop with the manufacturer. Every commercial entity in the distribution chain can be named: the manufacturer that created the product and its labeling, the wholesaler and distributor that moved it, and the retailer that sold it. The reach is deliberately broad so that an injured consumer always has a viable defendant.
Joint and several liability extends that protection in many jurisdictions. Each defendant is independently liable for the full amount of damages, regardless of its individual share of fault.2Legal Information Institute. Joint and Several Liability If the manufacturer is bankrupt but the retailer is solvent, the plaintiff can collect the full judgment from the retailer, which can then seek indemnification from upstream parties. The risk of an insolvent defendant shifts away from the consumer.
Defenses That Can Defeat a Claim
Learned Intermediary Doctrine
In pharmaceutical and medical device cases, manufacturers do not usually warn patients directly. The learned intermediary doctrine holds that the duty to warn is satisfied by providing adequate information to the prescribing physician, who weighs the risks and benefits for the specific patient. Every state and the District of Columbia have adopted some version of this rule.
The defense is not absolute. If the warnings to the physician were themselves inadequate, it fails. Some courts have questioned whether it should apply when drug companies advertise directly to consumers, but most jurisdictions have declined to create a formal exception.
Sophisticated User Defense
When a product is sold to professionals who already understand its risks, the manufacturer may argue it had no duty to warn them of dangers generally known within their trade. An industrial chemical sold to trained lab technicians may not require the same consumer-facing warnings as the same chemical sold in a retail store. This is different from the obvious-danger rule: the risk does not have to be apparent to anyone, just well-understood within the relevant professional community. Courts split on whether the defense applies in strict liability cases.
Comparative Fault and Product Misuse
Your own conduct can reduce or eliminate recovery. In comparative fault states, the jury assigns each party a percentage of fault and your recovery is reduced accordingly. A 30 percent fault finding means you collect 70 percent of your damages. Modified comparative fault states bar recovery entirely once your share exceeds 50 or 51 percent.
Product misuse works similarly. If you used the product in a way the manufacturer could not reasonably foresee, that defeats the claim. Foreseeability is the test. Using a screwdriver to pry open a paint can is foreseeable. Using a hair dryer in a filled bathtub is foreseeable enough that manufacturers warn about it. Modifying industrial equipment to bypass its safety systems is the kind of unforeseeable misuse that tends to sink a case.
Federal Preemption
When a federal agency regulates a product’s labeling, federal law may block state-law failure-to-warn claims. The answer depends on the product. For medical devices that went through the FDA’s premarket approval process, the Supreme Court held in Riegel v. Medtronic that state-law claims challenging safety or labeling are preempted. Prescription drugs are different. In Wyeth v. Levine, the Court held that federal approval of a drug label does not preempt state failure-to-warn claims, because manufacturers can usually comply with both federal rules and stricter state requirements.3Justia U.S. Supreme Court. Wyeth v Levine, 555 US 555 (2009) For most consumer products outside the medical device space, federal regulations set a floor rather than a ceiling, and state-law claims typically survive.
Warnings Owed After the Sale
A manufacturer’s obligation can continue after the product leaves the store. The Restatement (Third) of Torts Section 10 recognizes a post-sale duty to warn when a reasonable seller in the same position would have done so. Four conditions have to converge: the seller learns the product poses a substantial risk, the affected consumers can be identified, a warning can be communicated and acted on effectively, and the severity of the risk justifies the cost of issuing one.
In practice this duty surfaces through recall notices, safety bulletins, and software updates. It is not unlimited. If a minor risk emerges 15 years after a product was sold to millions of anonymous retail customers, the burden of reaching those buyers may outweigh the benefit. But when a company has a customer database and discovers a serious defect, silence is legally dangerous.
What You Can Recover
Economic Damages
Economic damages cover measurable financial losses: past and future medical bills, lost income and earning capacity, property damage, and costs like home modifications or personal care if the injury causes long-term disability. These numbers tie to receipts, pay stubs, and medical records.
Non-Economic Damages
Non-economic damages compensate for intangible harm: physical pain, emotional distress, long-term reduction in quality of life, and loss of consortium. They are harder to quantify and often make up the largest share of a verdict. Some states cap non-economic damages, with limits as low as $250,000. Others impose no statutory ceiling.
Punitive Damages
Punitive damages punish defendants for egregious or intentional wrongdoing rather than compensate the plaintiff. They apply when a manufacturer knew about a serious risk and deliberately concealed it or chose not to warn in order to protect sales. The Supreme Court has signaled that punitive awards exceeding a single-digit ratio to compensatory damages will face constitutional scrutiny, though higher ratios can survive where particularly outrageous conduct caused relatively small economic harm. State standards vary.
One rule works in the plaintiff’s favor across most jurisdictions: the collateral source rule. Payments from your own health insurance or other benefits are not deducted from the defendant’s liability. Most private insurance contracts contain reimbursement provisions to prevent a true double recovery.
How Long You Have to File
Product liability claims carry strict deadlines. Miss them and the case is gone regardless of its merits. Two separate clocks run in many states, and confusing them is a common and costly mistake.
The statute of limitations sets the window after you discover (or reasonably should have discovered) the injury and its connection to the product. Most states allow two to four years for personal injury claims. The discovery rule can delay the start of this clock. If a chemical exposure causes a disease that takes years to appear, the clock may not start until diagnosis.
The statute of repose is harder. It is an absolute deadline measured from the date the product was first sold or delivered, no matter when the injury occurred or was discovered. Roughly half the states have enacted product liability statutes of repose, most falling between 10 and 15 years. If a product you bought 13 years ago injures you today, a 12-year statute of repose bars the claim even if you just learned about the defect. Investigate promptly.
Evidence to Preserve
Keep the product in the exact condition it was in when you were hurt. Do not throw it away, repair it, or let anyone else handle it. The physical item is the single most important piece of evidence because an expert needs to examine the labels, warnings, and packaging as they existed at the time of the injury. Alterations give the defense room to argue the original warning was adequate.
Save the original packaging, instruction manual, inserts, and any promotional materials. These establish what the manufacturer actually told you. Photograph the product and its packaging as soon as possible after the injury, since the placement, size, and wording of warning labels are central to proving a marketing defect.
Gather medical records that link your injury directly to the product and document treatment and prognosis. Pair them with proof of purchase, whether a receipt, credit card statement, or online order confirmation, so you can tie yourself to the specific defendants. Keep organized records of medical bills, pharmacy costs, and missed work to support the economic damages calculation.
How a Case Moves Through Court
The lawsuit begins with a complaint identifying the defendants, describing the defective warning or its absence, explaining how the defect caused your injury, and stating the damages you seek. It is filed with the court clerk along with a filing fee. The clerk issues a summons for each defendant.
The summons is delivered through service of process. Most jurisdictions allow service by any adult who is not a party to the case, including professional process servers.4Legal Information Institute. Service of Process In federal court, a defendant has 21 days after service to respond, extended to 60 days if formal service was waived.5Legal Information Institute. Federal Rules of Civil Procedure Rule 12 – Defenses and Objections State court deadlines typically fall between 20 and 30 days. A defendant that fails to respond on time risks a default judgment.
After the response, the case enters discovery. Both sides exchange documents, take depositions, and retain expert witnesses. In failure-to-warn cases, discovery often zeroes in on the manufacturer’s internal records: what the company knew about the product’s risks, when it learned, and which labeling alternatives it considered and rejected. This phase can run for months or longer.
Multidistrict Litigation
When the same product injures many people across the country, individual federal lawsuits may be consolidated into a multidistrict litigation proceeding. Under 28 U.S.C. Section 1407, the Judicial Panel on Multidistrict Litigation can transfer cases sharing common questions of fact to a single district for coordinated pretrial proceedings when doing so serves the convenience of parties and witnesses and promotes efficient management.6Office of the Law Revision Counsel. 28 USC 1407 – Multidistrict Litigation Each transferred case remains its own action but shares discovery and expert testimony with the others. Major pharmaceutical and consumer product failure-to-warn cases often move through MDL. If your claim involves a widely distributed product, there may already be an MDL proceeding you can join.